IQV IQVIA Holdings Inc.
Stock · NYSE · United States · Healthcare · US46266C1053
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by IQVIA Holdings Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
271.83 USD
+2.62%
52-week range
154.50 – 284.50
Dividend yield—
Market cap44.8B
NowoTrade score
51 Grade A
Price history
Daily prices in USD.
Updated 07 Nov 2026 09:37. Information, not advice.
Results
Next results
11 Feb 2027
in 96 days · 08:00 · estimate 3.58
Last results
3.34 vs 3.28 estimated
27 Oct 2026 · Beat +2.0%
Beat the estimate
8 of 12
0 missed · 4 in line · 3 beats in a row
Average surprise
+1.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 08:00 | 3.58 | — | — | Upcoming |
| 27 Oct 2026 07:00 | 3.28 | 3.34 | +2.0% | Beat |
| 28 Jul 2026 07:00 | 3.03 | 3.15 | +3.9% | Beat |
| 05 May 2026 07:00 | 2.82 | 2.90 | +3.0% | Beat |
| 05 Feb 2026 07:00 | 3.40 | 3.42 | +0.7% | In line |
| 28 Oct 2025 07:00 | 2.98 | 3.00 | +0.8% | In line |
| 22 Jul 2025 07:00 | 2.77 | 2.81 | +1.4% | Beat |
| 06 May 2025 07:00 | 2.63 | 2.70 | +2.6% | Beat |
| 06 Feb 2025 07:00 | 3.11 | 3.12 | +0.4% | In line |
| 31 Oct 2024 07:00 | 2.81 | 2.84 | +1.0% | Beat |
| 22 Jul 2024 07:00 | 2.56 | 2.64 | +3.0% | Beat |
| 02 May 2024 07:00 | 2.48 | 2.54 | +2.4% | Beat |
| 14 Feb 2024 07:00 | 2.82 | 2.84 | +0.7% | In line |
| 01 Nov 2023 16:00 | 2.45 | 2.49 | +1.8% | Beat |
| 01 Aug 2023 07:00 | 2.37 | 2.43 | +2.5% | Beat |
| 27 Apr 2023 07:00 | 2.41 | 2.45 | +1.7% | Beat |
| 10 Feb 2023 07:00 | 2.76 | 2.78 | +0.6% | In line |
| 26 Oct 2022 07:00 | 2.38 | 2.48 | +4.0% | Beat |
| 21 Jul 2022 07:00 | 2.38 | 2.44 | +2.4% | Beat |
| 27 Apr 2022 07:00 | 2.42 | 2.47 | +2.2% | Beat |
| 15 Feb 2022 07:00 | 2.43 | 2.55 | +4.8% | Beat |
| 21 Oct 2021 07:00 | 2.12 | 2.17 | +2.2% | Beat |
| 27 Jul 2021 07:00 | 2.08 | 2.13 | +2.5% | Beat |
| 22 Apr 2021 07:00 | 1.86 | 2.18 | +17.5% | Beat |
| 10 Feb 2021 07:00 | 2.01 | 2.11 | +5.2% | Beat |
| 20 Oct 2020 07:00 | 1.54 | 1.63 | +5.9% | Beat |
| 22 Jul 2020 07:00 | 1.06 | 1.18 | +11.7% | Beat |
| 28 Apr 2020 08:00 | 1.49 | 1.50 | +0.8% | In line |
| 12 Feb 2020 07:00 | 1.72 | 1.74 | +1.1% | Beat |
| 30 Oct 2019 07:00 | 1.57 | 1.60 | +1.7% | Beat |
| 24 Jul 2019 07:00 | 1.49 | 1.53 | +2.5% | Beat |
| 01 May 2019 07:00 | 1.51 | 1.53 | +1.5% | Beat |
| 14 Feb 2019 07:00 | 1.47 | 1.50 | +2.0% | Beat |
| 22 Oct 2018 07:00 | 1.39 | 1.42 | +2.2% | Beat |
| 24 Jul 2018 07:00 | 1.23 | 1.29 | +4.6% | Beat |
| 02 May 2018 07:00 | 1.27 | 1.34 | +5.2% | Beat |
| 14 Feb 2018 07:00 | 1.34 | 1.40 | +4.1% | Beat |
| 26 Oct 2017 07:00 | 1.14 | 1.19 | +4.7% | Beat |
| 03 Aug 2017 07:00 | 1.05 | 1.09 | +3.8% | Beat |
| 03 May 2017 07:00 | 0.96 | 1.01 | +5.4% | Beat |
| 14 Feb 2017 07:00 | 1.05 | 0.46 | -56.7% | Miss |
| 02 Nov 2016 07:00 | 0.98 | 1.00 | +1.8% | Beat |
| 27 Jul 2016 06:00 | 0.90 | 0.93 | +3.3% | Beat |
| 03 May 2016 06:00 | 0.86 | 0.89 | +3.2% | Beat |
| 11 Feb 2016 06:00 | 0.87 | 0.90 | +3.8% | Beat |
| 28 Oct 2015 06:00 | 0.81 | 0.94 | +15.5% | Beat |
| 29 Jul 2015 06:00 | 0.70 | 0.78 | +12.1% | Beat |
| 29 Apr 2015 06:00 | 0.71 | 0.72 | +1.6% | Beat |
| 12 Feb 2015 06:00 | 0.67 | 0.71 | +5.4% | Beat |
| 30 Oct 2014 06:00 | 0.64 | 0.65 | +1.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 16.3B | +5.9% | 1.4B | 8.3% | 7.84 | +4.7% | 2.1B |
| 2024 | 15.4B | +2.8% | 1.4B | 8.9% | 7.49 | +2.7% | 2.1B |
| 2023 | 15B | +4.0% | 1.4B | 9.1% | 7.29 | +27.4% | 1.5B |
| 2022 | 14.4B | — | 1.1B | 7.6% | 5.72 | — | 1.6B |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 06 Nov 2026 | 264.21 | 273.46 | 261.20 | 271.83 | +2.62% | 1,398,400 | |
| 05 Nov 2026 | 267.28 | 267.28 | 261.00 | 264.88 | +0.41% | 1,738,200 | |
| 04 Nov 2026 | 263.04 | 269.28 | 260.44 | 263.79 | +0.46% | 1,379,500 | |
| 03 Nov 2026 | 255.65 | 263.99 | 252.38 | 262.59 | +1.61% | 1,321,600 | |
| 02 Nov 2026 | 269.43 | 270.00 | 257.35 | 258.44 | -3.33% | 1,368,100 | |
| 30 Oct 2026 | 274.91 | 274.91 | 263.21 | 267.33 | -2.81% | 1,150,200 | |
| 29 Oct 2026 | 276.86 | 279.36 | 272.82 | 275.06 | -1.43% | 1,429,300 | |
| 28 Oct 2026 | 270.15 | 282.42 | 269.00 | 279.04 | +2.76% | 1,722,500 | |
| 27 Oct 2026 | 267.50 | 284.50 | 266.61 | 271.55 | -0.75% | 2,097,200 | |
| 26 Oct 2026 | 280.50 | 281.84 | 270.92 | 273.60 | -2.06% | 1,689,100 | |
| 23 Oct 2026 | 276.56 | 279.58 | 274.67 | 279.36 | +0.37% | 981,200 | |
| 22 Oct 2026 | 274.99 | 282.98 | 273.80 | 278.32 | +0.61% | 1,672,400 | |
| 21 Oct 2026 | 264.46 | 277.28 | 263.97 | 276.63 | +3.28% | 1,755,900 | |
| 20 Oct 2026 | 269.20 | 272.08 | 263.28 | 267.85 | +0.74% | 1,688,900 | |
| 19 Oct 2026 | 268.10 | 269.87 | 264.07 | 265.88 | -0.38% | 834,600 | |
| 16 Oct 2026 | 271.92 | 272.98 | 263.21 | 266.90 | -1.53% | 1,037,000 | |
| 15 Oct 2026 | 265.10 | 271.68 | 261.77 | 271.04 | +3.45% | 1,456,600 | |
| 14 Oct 2026 | 264.37 | 266.66 | 260.82 | 262.01 | +0.51% | 1,117,500 | |
| 13 Oct 2026 | 263.49 | 265.00 | 259.61 | 260.68 | -0.58% | 1,359,700 | |
| 12 Oct 2026 | 260.23 | 263.82 | 257.30 | 262.21 | +0.90% | 1,085,600 | |
| 09 Oct 2026 | 257.73 | 263.51 | 257.73 | 259.88 | +0.39% | 972,300 | |
| 08 Oct 2026 | 256.01 | 259.95 | 252.56 | 258.88 | +0.30% | 988,400 | |
| 07 Oct 2026 | 261.41 | 261.41 | 255.05 | 258.11 | -0.72% | 1,406,100 | |
| 06 Oct 2026 | 269.43 | 274.28 | 259.79 | 259.98 | -2.30% | 1,105,200 | |
| 05 Oct 2026 | 258.51 | 266.91 | 258.51 | 266.09 | +3.05% | 1,688,100 |
Page 1 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- IQV Q3 deep dive: AI adoption and clinical momentum drive growth, guidance raised (opens in a new tab) StockStory · 30 Oct 2026 21:31
- 5 revealing analyst questions from IQVIA’s Q3 earnings call (opens in a new tab) StockStory · 30 Oct 2026 21:15
- IQVIA (IQV) Q3 Earnings Beat Meets Valuation And Debt Questions (opens in a new tab) Simply Wall St. · 28 Oct 2026 08:09
- What IQVIA (IQV) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 27 Oct 2026 20:04
- IQVIA (IQV) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 27 Oct 2026 18:14
- IQVIA Holdings Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 27 Oct 2026 17:50
- IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y (opens in a new tab) Zacks · 27 Oct 2026 13:42
- IQVIA’s (NYSE:IQV) Q3 2026: beats on revenue (opens in a new tab) StockStory · 27 Oct 2026 11:58
- IQVIA: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 27 Oct 2026 11:15
- IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 27 Oct 2026 11:15
- IQVIA (IQV) Q3 earnings report preview: what to look for (opens in a new tab) StockStory · 26 Oct 2026 10:06
- Locking in Gains: Portfolio Discipline Triggers IQVIA Holding (IQV) Trim After Q2 Beat (opens in a new tab) Insider Monkey · 23 Oct 2026 17:20
- From Headwinds to Full Valuation: The Disciplined Exit of IQVIA Holdings (IQV) (opens in a new tab) Insider Monkey · 23 Oct 2026 16:44
- IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know (opens in a new tab) Zacks · 22 Oct 2026 13:58
- IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? (opens in a new tab) Zacks · 20 Oct 2026 14:00
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 264.88 USD
- Market cap
- 44.8B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 12.7 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 20.2 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 9.4 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 10.4 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 8.2 / 10 |
|
- Heavy debt: net debt is 4.5× EBITDA
- Total debt has risen three years in a row
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 33.07× | Weak | 31.09× |
| P/E (forward) | 19.14× | Fair | 14.98× |
| Price / book | 6.73× | Weak | 3.94× |
| Price / sales | 2.59× | Fair | 3.37× |
| EV / EBITDA | 18.5× | Weak | 12.96× |
| Free cash flow yield | 4.7% | Fair | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 33.1% | Fair | 59.2% |
| Operating margin | 13.7% | Fair | 7.4% |
| Net margin | 8.1% | Fair | 3.4% |
| Return on equity | 21.4% | Good | 5.7% |
| Return on assets | 5.1% | Fair | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 4.2% | Fair | 10.8% |
| EPS growth / year | 11.1% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 2.4× | Weak | 0.46× |
| Net debt / EBITDA | 4.46× | Weak | 1.5× |
| Interest cover | 3.14× | Fair | 3.26× |
| Current ratio | 0.83× | Weak | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow IQV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.